110 related articles for article (PubMed ID: 24368525)
21. Combined 18F-fluorocholine and 18F-fluoride positron emission tomography/computed tomography imaging for staging of high-risk prostate cancer.
Kjölhede H; Ahlgren G; Almquist H; Liedberg F; Lyttkens K; Ohlsson T; Bratt O
BJU Int; 2012 Nov; 110(10):1501-6. PubMed ID: 22502982
[TBL] [Abstract][Full Text] [Related]
22. Incidental finding of parathyroid adenoma with 11C-choline PET/CT.
Mapelli P; Busnardo E; Magnani P; Freschi M; Picchio M; Gianolli L; Messa C
Clin Nucl Med; 2012 Jun; 37(6):593-5. PubMed ID: 22614195
[TBL] [Abstract][Full Text] [Related]
23. 11C-choline PET/CT predicts prostate cancer-specific survival in patients with biochemical failure during androgen-deprivation therapy.
Giovacchini G; Picchio M; Garcia-Parra R; Briganti A; Abdollah F; Gianolli L; Schindler C; Montorsi F; Messa C; Fazio F
J Nucl Med; 2014 Feb; 55(2):233-41. PubMed ID: 24408897
[TBL] [Abstract][Full Text] [Related]
24. ¹⁸F-NaF PET/CT and ¹¹C-Choline PET/CT for the initial detection of metastatic disease in prostate cancer: overview and potential utilization.
Koo PJ; David Crawford E
Oncology (Williston Park); 2014 Dec; 28(12):1057-62, 1064-5. PubMed ID: 25738199
[TBL] [Abstract][Full Text] [Related]
25. Effect of erythropoietin on bone marrow uptake of 18F-fluorocholine in prostate cancer: comparison with 18F-fluoride uptake.
Balogova S; Huchet V; Egrot C; Michaud L; Paycha F; Kerrou K; Montravers F; Cussenot O; Talbot JN
Clin Nucl Med; 2013 Mar; 38(3):200-2. PubMed ID: 23354033
[TBL] [Abstract][Full Text] [Related]
26. [Pitfalls with 18F-choline PET/CT in patients with prostate cancer].
García Vicente AM; Núñez García A; Soriano Castrejón AM; Jiménez Londoño GA; Cordero García JM; Palomar Muñoz A
Rev Esp Med Nucl Imagen Mol; 2013 Jan; 32(1):37-9. PubMed ID: 23177342
[TBL] [Abstract][Full Text] [Related]
27. Bone metastases from prostate cancer: 18F-fluoride PET/CT in a patient with discordant bone scintigraphy and 11C-choline PET/CT.
Garcia G; Riera E; Valls E; Soler M; Bassa P; Moragas M; Lomeña F
Clin Nucl Med; 2013 Feb; 38(2):120-4. PubMed ID: 23334127
[TBL] [Abstract][Full Text] [Related]
28. Dual-phase 11C-choline PET/computed tomography in the early evaluation of prostate cancer recurrence.
Garcia JR; Cuberas G; Riera E; Soler M; Moragas M; Lomeña F
Nucl Med Commun; 2015 Jan; 36(1):8-15. PubMed ID: 25299466
[TBL] [Abstract][Full Text] [Related]
29. Incidental detection of Leydig cell tumor via fluorine-18-Choline PET/CT in a patient with recurrent prostate cancer disease.
Cimitan M; Hodolič M; Maffione AM; Borsatti E; Urso C; Colletti PM; Rubello D
Clin Nucl Med; 2013 Sep; 38(9):752-4. PubMed ID: 23856823
[TBL] [Abstract][Full Text] [Related]
30. [First experience of using positron emission tomography with 11C-choline in prostate cancer (PC)].
Granov AM; Tiutin LA; Ryzhkova DV; Shkol'nik MI; Andabekov TT; Mostova MI; Shatik SV; Kostenikov NA; Zaĭtsev VV; Tlostanova MS; Stanzhevskiĭ AA; Panfilenko AA; Arzumanov AA; Metelëv VV; Iliushchenko IuR
Vopr Onkol; 2013; 59(4):460-4. PubMed ID: 24032219
[TBL] [Abstract][Full Text] [Related]
31. Choline PET/CT for prostate cancer: main clinical applications.
Fuccio C; Rubello D; Castellucci P; Marzola MC; Fanti S
Eur J Radiol; 2011 Nov; 80(2):e50-6. PubMed ID: 20800404
[TBL] [Abstract][Full Text] [Related]
32. Phantom studies and clinical application of high resolution, image reconstruction using (18)F-fluoromethylcholine PET/CT for prostate cancer.
Zielinski A; Behrendt FF; Verburg FA; Mottaghy FM; Krohn T
Hell J Nucl Med; 2014; 17(3):194-9. PubMed ID: 25397625
[TBL] [Abstract][Full Text] [Related]
33. Increased choline uptake in macrophages and prostate cancer cells does not allow for differentiation between benign and malignant prostate pathologies.
Schwarz T; Seidl C; Schiemann M; Senekowitsch-Schmidtke R; Krause BJ
Nucl Med Biol; 2016 Jun; 43(6):355-9. PubMed ID: 27260776
[TBL] [Abstract][Full Text] [Related]
34. Spine metastases in prostate cancer: comparison of technetium-99m-MDP whole-body bone scintigraphy, [(18) F]choline positron emission tomography(PET)/computed tomography (CT) and [(18) F]NaF PET/CT.
Poulsen MH; Petersen H; Høilund-Carlsen PF; Jakobsen JS; Gerke O; Karstoft J; Steffansen SI; Walter S
BJU Int; 2014 Dec; 114(6):818-23. PubMed ID: 24314065
[TBL] [Abstract][Full Text] [Related]
35. Role of 11C-choline PET/CT in the restaging of prostate cancer patients showing a single lesion on bone scintigraphy.
Fuccio C; Castellucci P; Schiavina R; Santi I; Allegri V; Pettinato V; Boschi S; Martorana G; Al-Nahhas A; Rubello D; Fanti S
Ann Nucl Med; 2010 Jul; 24(6):485-92. PubMed ID: 20544323
[TBL] [Abstract][Full Text] [Related]
36. Unusual F-18 choline uptake in penile metastasis from prostate cancer.
Hodolič M; Fettich J; Cimitan M; Kragelj B; Goldsmith SJ
Clin Nucl Med; 2012 Apr; 37(4):e89-90. PubMed ID: 22391732
[No Abstract] [Full Text] [Related]
37. Imaging prostate cancer with 11C-choline PET/CT.
Reske SN; Blumstein NM; Neumaier B; Gottfried HW; Finsterbusch F; Kocot D; Möller P; Glatting G; Perner S
J Nucl Med; 2006 Aug; 47(8):1249-54. PubMed ID: 16883001
[TBL] [Abstract][Full Text] [Related]
38. 18F-Fluoride positron emission tomography and positron emission tomography/computed tomography.
Even-Sapir E; Mishani E; Flusser G; Metser U
Semin Nucl Med; 2007 Nov; 37(6):462-9. PubMed ID: 17920353
[TBL] [Abstract][Full Text] [Related]
39. Localization of primary prostate cancer with dual-phase 18F-fluorocholine PET.
Kwee SA; Wei H; Sesterhenn I; Yun D; Coel MN
J Nucl Med; 2006 Feb; 47(2):262-9. PubMed ID: 16455632
[TBL] [Abstract][Full Text] [Related]
40. Early biochemical relapse after radical prostatectomy: which prostate cancer patients may benefit from a restaging 11C-Choline PET/CT scan before salvage radiation therapy?
Castellucci P; Ceci F; Graziani T; Schiavina R; Brunocilla E; Mazzarotto R; Pettinato C; Celli M; Lodi F; Fanti S
J Nucl Med; 2014 Sep; 55(9):1424-9. PubMed ID: 24935990
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
